How does ketamine elicit a rapid antidepressant response?

Berman, 2000, Antidepressant effects of ketamine in depressed patients, Biol Psychiatry, 47, 351, 10.1016/S0006-3223(99)00230-9 Price, 2009, Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression, Biol Psychiatry, 66, 522, 10.1016/j.biopsych.2009.04.029 Zarate, 2006, A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression, Arch Gen Psychiatry, 63, 856, 10.1001/archpsyc.63.8.856 Diazgranados, 2010, A randomized add-on trial of an N-methyl-d-aspartate antagonist in treatment-resistant bipolar depression, Arch Gen Psychiatry, 67, 793, 10.1001/archgenpsychiatry.2010.90 Zarate, 2012, Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial, Biol Psychiatry, 71, 939, 10.1016/j.biopsych.2011.12.010 Autry, 2011, NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses, Nature, 475, 91, 10.1038/nature10130 Li, 2010, mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists, Science, 329, 959, 10.1126/science.1190287 Maeng, 2008, Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors, Biol Psychiatry, 63, 349, 10.1016/j.biopsych.2007.05.028 Liu, 2012, Brain-derived neurotrophic factor Val66Met allele impairs basal and ketamine-stimulated synaptogenesis in prefrontal cortex, Biol Psychiatry, 71, 996, 10.1016/j.biopsych.2011.09.030 Malberg, 2000, Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus, J Neurosci, 20, 9104, 10.1523/JNEUROSCI.20-24-09104.2000 Santarelli, 2003, Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants, Science, 301, 805, 10.1126/science.1083328 Tsankova, 2006, Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action, Nat Neurosci, 9, 519, 10.1038/nn1659 Gideons, 2014, Mechanisms underlying differential effectiveness of memantine and ketamine in rapid antidepressant responses, Proc Natl Acad Sci U S A, 111, 8649, 10.1073/pnas.1323920111 Nosyreva, 2013, Acute suppression of spontaneous neurotransmission drives synaptic potentiation, J Neurosci, 33, 6990, 10.1523/JNEUROSCI.4998-12.2013 Kavalali, 2012, Synaptic mechanisms underlying rapid antidepressant action of ketamine, Am J Psychiatry, 169, 1150, 10.1176/appi.ajp.2012.12040531 Monteggia, 2013, The role of eukaryotic elongation factor 2 kinase in rapid antidepressant action of ketamine, Biol Psychiatry, 73, 1199, 10.1016/j.biopsych.2012.09.006 Duman, 2006, A neurotrophic model for stress-related mood disorders, Biol Psychiatry, 59, 1116, 10.1016/j.biopsych.2006.02.013 Monteggia, 2004, Essential role of brain-derived neurotrophic factor in adult hippocampal function, Proc Natl Acad Sci U S A, 101, 10827, 10.1073/pnas.0402141101 Nibuya, 1995, Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments, J Neurosci, 15, 7539, 10.1523/JNEUROSCI.15-11-07539.1995 Adachi, 2008, Selective loss of brain-derived neurotrophic factor in the dentate gyrus attenuates antidepressant efficacy, Biol Psychiatry, 63, 642, 10.1016/j.biopsych.2007.09.019 Hoshaw, 2005, Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects, Brain Res, 1037, 204, 10.1016/j.brainres.2005.01.007 Shirayama, 2002, Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression, J Neurosci, 22, 3251, 10.1523/JNEUROSCI.22-08-03251.2002 Siuciak, 1997, Antidepressant-like effect of brain-derived neurotrophic factor (BDNF), Pharmacol Biochem Behav, 56, 131, 10.1016/S0091-3057(96)00169-4 Ferguson, 2007, An open-label, flexible-dose study of memantine in major depressive disorder, Clin Neuropharmacol, 30, 136, 10.1097/WNF.0b013e3180314ae7 Lenze, 2012, Memantine for late-life depression and apathy after a disabling medical event: a 12-week, double-blind placebo-controlled pilot study, Int J Geriatr Psychiatry, 27, 974, 10.1002/gps.2813 Zarate, 2006, A double-blind, placebo-controlled study of memantine in the treatment of major depression, Am J Psychiatry, 163, 153, 10.1176/appi.ajp.163.1.153 Sanacora, 2009, Do glutamatergic agents represent a new class of antidepressant drugs? Part 2, J Clin Psychiatry, 70, 1604, 10.4088/JCP.09ac05757blu Sanacora, 2009, Do glutamatergic agents represent a new class of antidepressant drugs? Part 1, J Clin Psychiatry, 70, 1473, 10.4088/JCP.09ac05680blu Sanacora, 2013, Lanicemine: a low-trapping NMDA channel blocker produces sustained antidepressant efficacy with minimal psychotomimetic adverse effects, Mol Psychiatry Berton, 2006, Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress, Science, 311, 864, 10.1126/science.1120972 Li, 2011, Synaptic potentiation onto habenula neurons in the learned helplessness model of depression, Nature, 470, 535, 10.1038/nature09742 Cai, 2013, Local potentiation of excitatory synapses by serotonin and its alteration in rodent models of depression, Nat Neurosci, 16, 464, 10.1038/nn.3355 Arendt, 2013, Chronic inactivation of a neural circuit enhances LTP by inducing silent synapse formation, J Neurosci, 33, 2087, 10.1523/JNEUROSCI.3880-12.2013 Izumi, 2014, Metaplastic effects of subanesthetic ketamine on CA1 hippocampal function, Neuropharmacology, 86C, 273, 10.1016/j.neuropharm.2014.08.002 Nabavi, 2013, Metabotropic NMDA receptor function is required for NMDA receptor-dependent long-term depression, Proc Natl Acad Sci, 110, 4027, 10.1073/pnas.1219454110 Monteggia, 2013, Scopolamine and ketamine: evidence of convergence?, Biol Psychiatry, 74, 712, 10.1016/j.biopsych.2013.08.011